CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2999
-0.0140 (-4.47%)
Aug 29, 2025, 3:58 PM EDT
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $376.00 million as of August 29, 2025. Its market cap has increased by 171.53% in one year.
Market Cap
376.00M
Enterprise Value
391.44M
Revenue
n/a
Ranking
n/a
PE Ratio
164.87
Stock Price
$0.30
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 376.00M, an increase of 6,689.98%. That is a compound annual growth rate of 23.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 376.00M | 179.27% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | 3.21B | 695.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 838.96M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 654.83M |
| Elite Pharmaceuticals | 610.28M |
| Northwest Biotherapeutics | 390.55M |
| American Oncology Network | 359.30M |
| Silence Therapeutics | 245.62M |